Literature DB >> 7679827

FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression.

M L Jordan1, R Shapiro, C A Vivas, V P Scantlebury, F S Darras, G Carrieri, J McCauley, A J Demetris, P Randhawa, C Jensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7679827      PMCID： PMC2955425     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  10 in total

1.  Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA.

Authors:  A Zeevi; G Eiras; F H Bach; J J Fung; S Todo; T Starzl; R J Duquesnoy
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

2.  FK 506 conversion of renal allografts failing cyclosporine immunosuppression.

Authors:  M L Jordan; R Shapiro; C W Jensen; V Scantlebury; J Fung; A Tzakis; J McCauley; A Jain; J Demetrius; P Randhawa
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  Kidney transplantation under FK 506 immunosuppression.

Authors:  R Shapiro; M Jordan; J Fung; J McCauley; J Johnston; Y Iwaki; A Tzakis; T Hakala; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

4.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

5.  Kidney transplantation under FK 506.

Authors:  T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal:  JAMA       Date:  1990-07-04       Impact factor: 56.272

6.  Sequential antilymphoblast globulin and cyclosporine for renal transplantation.

Authors:  B G Sommer; M Henry; R M Ferguson
Journal:  Transplantation       Date:  1987-01       Impact factor: 4.939

7.  Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function.

Authors:  A J Matas; V A Tellis; T A Quinn; D Glicklich; R Soberman; F J Veith
Journal:  Transplantation       Date:  1988-02       Impact factor: 4.939

8.  A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation.

Authors:  A Tarantino; A Aroldi; L Stucchi; G Montagnino; L Mascaretti; A Vegeto; C Ponticelli
Journal:  Transplantation       Date:  1991-07       Impact factor: 4.939

9.  RS-61443--a phase I clinical trial and pilot rescue study.

Authors:  H W Sollinger; M H Deierhoi; F O Belzer; A G Diethelm; R S Kauffman
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

10.  A randomized clinical trial of cyclosporine in cadaveric renal transplantation.

Authors: 
Journal:  N Engl J Med       Date:  1983-10-06       Impact factor: 91.245
  10 in total
  3 in total

1.  Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.

Authors:  A C Tsamandas; S M Pham; E C Seaberg; O Pappo; R L Kormos; A Kawai; B P Griffith; A Zeevi; R Duquesnoy; J J Fung; T E Starzl; A J Demetris
Journal:  J Heart Lung Transplant       Date:  1997-07       Impact factor: 10.247

Review 2.  The use of tacrolimus in renal transplantation.

Authors:  M L Jordan; R Shapiro; C A Vivas; V Scantlebury; H A Gritsch; D Ellis; N Gilboa; T E Starzl
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 3.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.